SHANGHAI, May 14 (Reuters) - German healthcare and materials group Merck KGaA (MRCG.DE), opens new tab has dropped a surcharge on life sciences sector orders within China following the U.S.-China ...

China was producing copies of U.S. drugs, but with a big lag time. Armed with the ambition to change that and ample industry experience, she launched a biotech company in 2012 with two former Crown ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations, as the company temporarily paused shipments of a key vaccine into China. Stream Los Angeles News ...